SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-681546
Filing Date
2016-08-15
Accepted
2016-08-15 12:16:59
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d225217d10q.htm 10-Q 668846
2 EX-10.1 d225217dex101.htm EX-10.1 16690
3 EX-10.2 d225217dex102.htm EX-10.2 18727
4 EX-10.3 d225217dex103.htm EX-10.3 19600
5 EX-10.4 d225217dex104.htm EX-10.4 23384
6 EX-31.1 d225217dex311.htm EX-31.1 5984
7 EX-31.2 d225217dex312.htm EX-31.2 5993
8 EX-32.1 d225217dex321.htm EX-32.1 4216
  Complete submission text file 0001193125-16-681546.txt   3801703

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT sndx-20160630.xml EX-101.INS 639829
10 XBRL TAXONOMY EXTENSION SCHEMA sndx-20160630.xsd EX-101.SCH 44756
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20160630_cal.xml EX-101.CAL 59018
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20160630_def.xml EX-101.DEF 169326
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20160630_lab.xml EX-101.LAB 345028
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20160630_pre.xml EX-101.PRE 259438
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 161831184
SIC: 2834 Pharmaceutical Preparations